Thus, we aimed to analyse the prognostic role of tumour PD-L1 expression and routinely available pathological and clinical biomarkers including Ki-67 index and circulating C-reactive protein (CRP) levels in patients diagnosed with MPE. This evidence concerns the gene CD274 and neoplasm.